Biogen goes deep into biosimilars, slapping down $700M for a major stake in Samsung Bioepis

Biogen goes deep into biosimilars, slapping down $700M for a major stake in Samsung Bioepis

Source: 
Endpoints
snippet: 

Biogen $BIIB was pretty careful when it allied with Samsung Bioepis back in 2011 — when George Scangos was CEO — taking a small minority stake in the company as it dipped its toe into biosimilar waters.